Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05396287 · ClinicalTrials.gov registry record

Blood Vessel Anatomy and Blood Flow Regulation

A clinical trial of Healthy and Brain Blood Flow, sponsored by University of Wisconsin, Madison.

Active
Registry status
80
Enrollment target
1
Study location

NCT05396287: Active study of Healthy and Brain Blood Flow, sponsored by University of Wisconsin, Madison.

NCT05396287 is a study of Healthy and Brain Blood Flow that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 80 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05396287, a study of Healthy and Brain Blood Flow, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.

ACTIVE NOT RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

Brain blood flow regulation will be measured in response to environmental changes using MRI.

Primary Outcome

The change in brain blood flow using MRI will be measured in response to a hypercapnic breathing test. The participants cerebral vascular reactivity to hypercapnia will be compared between the controls (without VAH) and those with VAH.

Conditions Studied

Interventions

  • DEVICE MRI

Study Locations (1)

Wisconsin

  • University of Wisconsin-Madison - Madison

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-07-19
Est. Completion 2026-07
University of Wisconsin, Madison

1,039 total trials

What the registry record for NCT05396287 still lists

NCT05396287 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.

NCT05396287 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05396287 about?

NCT05396287 is a clinical study titled "Blood Vessel Anatomy and Blood Flow Regulation". Brain blood flow regulation will be measured in response to environmental changes using MRI.

What is the current status of trial NCT05396287?

This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2022-07-19. Estimated completion is 2026-07.

What conditions does trial NCT05396287 study?

This clinical trial studies the following conditions: Healthy, Brain Blood Flow.

What interventions are being tested in trial NCT05396287?

The interventions under investigation include: MRI (DEVICE).

Who is sponsoring clinical trial NCT05396287?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05396287 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05396287's enrollment target sits among peer trials

80 274th of 1090 higher than 802 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05396287, the US trial registry maintained by the National Library of Medicine. NCT05396287 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.